Skip to main content
. Author manuscript; available in PMC: 2014 Sep 24.
Published in final edited form as: Lancet Oncol. 2011 May 11;12(6):527–539. doi: 10.1016/S1470-2045(11)70094-8

Table 3.

Clinical and pathological complete responses

All patients p53 wild type p53 mutated
FEC arm
N=928
T-ET arm
N=928
FEC arm
N=427
T-ET arm
N=398
FEC arm
N=318
T-ET arm
N=326
Complete clinical response (cCR) 121 155 51 65 55 56
cCR% (95% CI) * 13.0 (10.9–15.5) 16.7 (14.4–19.3) 11.9 (9.0–15.4) 16.3 (12.8–20.3) 17.3 (13.3–21.9) 17.2 (13.2–21.7)
Odds ratio (98% CI)* 1.34 (0.99–1.82) 1.44 (0.90–2.30) 0.99 (0.61–1.61)
p-value 0.031 0.072 1.00
Complete pathological response (pCR) 218 246 79 80 93 97
pCR% (95% CI) * 23.5 (20.8–26.4) 26.5 (23.7–29.5) 18.5 (14.9–22.5) 20.1 (16.3–24.4) 29.2 (24.3–34.6) 29.8 (24.8–35.0)
Odds ratio (98% CI)* 1.17 (0.92–1.51) 1.11 (0.73–1.67) 1.02 (0.69–1.53)
p-value 0.148 0.60 0.93

Abbreviations

cCR: complete clinical response

pCR: pathological complete response

*

95% confidence intervals of observed rates (by arm) and estimates, and 98% confidence intervals of odds ratio (between arms)